The estimated Net Worth of Miriam J Paramore is at least $2.41 million dollars as of 2 December 2021. Ms. Paramore owns over 3,558 units of OptimizeRx Corp stock worth over $543,139 and over the last 7 years she sold OPRX stock worth over $1,407,750. In addition, she makes $462,350 as President at OptimizeRx Corp.
Sign up
Ms. Paramore OPRX stock SEC Form 4 insiders trading
Miriam has made over 13 trades of the OptimizeRx Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently she exercised 3,558 units of OPRX stock worth $26,721 on 2 December 2021.
The largest trade she's ever made was exercising 67,195 units of OptimizeRx Corp stock on 15 July 2021 worth over $211,664. On average, Miriam trades about 10,587 units every 85 days since 2017. As of 2 December 2021 she still owns at least 74,607 units of OptimizeRx Corp stock.
You can see the complete history of Ms. Paramore stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Miriam Paramore biography
Miriam J. Paramore serves as President of the Company. She has vast experience with healthcare companies, running businesses ranging from start-ups to large divisions of public and private companies. Her early career was spent at Ernst & Young, as a Healthcare Management Consultant. She has since occupied executive level and director positions at several healthcare companies. Most recently, from April 2016 to April 2017, Ms. Paramore served as COO and CTO of Lucro, Inc., a privately held company located in| Nashville, Tennessee focused on the healthcare sector. From March 2015 to February 2016, she served as Executive Vice President of PDX a privately held company in Fort Worth, Texas that provides health information technology for pharmacies. From May 2008 to December 2013, she served as Executive Vice President of Emdeon, Inc. in Nashville, Tennessee, a health information technology and tech-enabled services company.
What is the salary of Miriam Paramore?
As the President of OptimizeRx Corp, the total compensation of Miriam Paramore at OptimizeRx Corp is $462,350. There are 4 executives at OptimizeRx Corp getting paid more, with Stephen Silvestro having the highest compensation of $1,210,200.
How old is Miriam Paramore?
Miriam Paramore is 57, she's been the President of OptimizeRx Corp since 2017. There are 6 older and 7 younger executives at OptimizeRx Corp. The oldest executive at OptimizeRx Corp is Gus Halas, 69, who is the Chairman of the Board.
What's Miriam Paramore's mailing address?
Miriam's mailing address filed with the SEC is 400 WATER STREET, SUITE 200, , ROCHESTER, MI, 48307.
Insiders trading at OptimizeRx Corp
Over the last 2001 years, insiders at OptimizeRx Corp have traded over $20,012,815 worth of OptimizeRx Corp stock and bought 258,753 units worth $1,128,145 . The most active insiders traders include Investment Company, Inc. Awm, Bradley Louis Radoff et David Harrell. On average, OptimizeRx Corp executives and independent directors trade stock every 32 days with the average trade being worth of $183,485. The most recent stock trade was executed by Patrick D Spangler on 5 June 2024, trading 10,061 units of OPRX stock currently worth $73,244.
What does OptimizeRx Corp do?
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
What does OptimizeRx Corp's logo look like?
Complete history of Ms. Paramore stock trades at OptimizeRx Corp
OptimizeRx Corp executives and stock owners
OptimizeRx Corp executives and other stock owners filed with the SEC include:
-
Stephen Silvestro,
Chief Commercial Officer -
William Febbo,
Chief Executive Officer, Director -
William J. Febbo,
CEO & Director -
Stephen L. Silvestro,
Chief Commercial Officer -
Miriam Paramore,
President -
Douglas Baker,
Chief Financial Officer -
Gus Halas,
Chairman of the Board -
Lynn Vos,
Independent Director -
Patrick Spangler,
Independent Director -
James Lang,
Independent Director -
Angelo Campano,
Senior Vice President - Principal of Agency Channels -
Ron Both,
Investor Relations -
Gregory Wasson,
Director -
Todd Inman,
Chief Technology Officer -
Maira Alejandra,
Media Relations Mang. -
Todd Inman,
Chief Technology Officer -
Andrew Jacob D'Silva,
Sr. VP of Corp. Fin. -
Douglas P. Baker,
Exec. VP of Fin. & Accounting -
Edward Stelmakh C.M.A., M.B.A., MBA,
CFO & COO -
Rebecca Whitney,
Sr. VP of Commercial Operations -
Terence J. Hamilton,
Sr. VP of Pharma -
Sheryl Kearney,
HR Mang. -
Marion K Odence-Ford,
Gen. Counsel & Chief Compliance Officer -
Cathy Klema,
Director -
Ellen O'connor Vos,
Director -
Plc Wpp Luxembourg Gamma Th...,
-
Investment Company, Inc. Awm,
10% owner -
Bradley Louis Radoff,
10% owner -
Jack T Pinney,
Director -
Richard Kraniak,
10% owner -
David Lester,
Chairman of the Board -
David Harrell,
Chief Executive Officer -
Terrence Hamilton,
Vice President -
James M Brooks,
SVP of Business Development -
Brian J Dillon,
SR. VP OF PRODUCT & STRATEGY -
Brian Clark Mc Carthy,
Chief Revenue Officer -
Marion Odence Ford,
General Counsel and CCO -
Edward Stelmakh,
CFO/COO -
Doug Besch,
Chief Product Officer -
Theresa Greco,
Chief Commercial Officer